Menu
Recruiting NCT06670157

Detachable Clip-assisted Endoscopic Cyanoacrylate Injection in the Treatment of Gastric Varices

No phase Interventional Gastric Varices Bleeding

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Detachable Clip.
Who it may be relevant to
Registry conditions: Gastric Varices Bleeding. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Detachable Clip-assisted Endoscopic Cyanoacrylate Injection in the Treatment of Gastric Varices Under X-ray Perspective

Overview

A single-arm exploratory clinical study design was used to evaluate the safety and efficacy of a "modified sandwich injection" of tissue glue assisted by a detachable clip for the treatment of gastric varicose veins.

Interventions

  • Other Detachable Clip
    After the varicose vessels basically disappeared under the endoscope, the removable titanium clamp was removed

Primary outcome measures

  • Rebleeding rate at 6 weeks after treatment for gastric fundus varicose veins in cirrhosis [Time frame: 6 weeks]

Eligibility criteria

Inclusion criteria

  • The subject voluntarily signs the informed consent for this experiment; According to clinical manifestation, laboratory examination, imaging examination, or liver biopsy in the diagnosis of liver cirrhosis patients; The endoscopy diagnosed gastric varices (gastroesophageal varices, gastroesophageal varices type 2 or type 1 isolated gastric varices type 1); High risk of gastric varices or has a history of gastric varices bleeding. The initial fluid resuscitation patients before or after the recovery hemodynamic stability; The age of 18 years old or more.

Exclusion criteria

  • < 18 years old; Regional portal hypertension; Always have a liver transplant, via the jugular intrahepatic portal vein system bypass or splenectomy combined varices cut-out art history; A concurrent hepatorenal syndrome and/or multiple organ failure; Significant impact on survival of malignant tumor; Pregnancy or lactation; A known allergy to iodine.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

China · 1 center
  • Eastern Theater General Hospital — Nanjing

Identifiers

NCT: NCT06670157 · DZQH-KYLL-24-16

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗